Delta-Tocopherol and Colon Cancer
Written by Chrystal Moulton, Staff Writer. Delta-tocopherol significantly reduces lipid oxidation by 56.9%. (more…)
Written by Chrystal Moulton, Staff Writer. Delta-tocopherol significantly reduces lipid oxidation by 56.9%. (more…)
Written by Chrystal Moulton, Staff Writer. Delta-tocopherol led to a 2.7 fold increase in tumor cell death. (more…)
Written by Jessica Patella, ND. Supplementation with vitamin C after diagnosis of breast cancer is associated with a 19% reduction in mortality. (more…)
Written by Chrystal Moulton, Staff Writer. Intravenous vitamin C therapy offers many health benefits including its use as a potential chemotherapeutic agent. (more…)
Written by Marcia J. Egles, MD. Study shows how switching to a high-fiber, low-fat diet typical of rural Africans reduced gut inflammation and improved fiber digestion and risk markers for colon cancer in participating African Americans. (more…)
Written by Chrystal Moulton, Staff Writer. Vitamin C given intravenously achieves 66 times higher blood levels than vitamin C given orally and inhibits mesothelioma growth in a cell study. (more…)
Written by Joyce Smith, BS. Study shows a significant association between malignant mesothelioma and those who were exposed to asbestos and positive for SV40 virus.
(more…)
Written by Joyce Smith, BS. This study demonstrates a new and innovative application of Photo Dynamic Therapy for treating circulating tumor cells. (more…)
Written by Chrystal Moulton, Staff Writer. Research shows PD-L1 ligand is a valuable biomarker for predicting survival outcomes in patients with malignant mesotheliomas. (more…)
Written by Chrystal Moulton, Staff Writer. Treatment of malignant pleural mesothelioma with genetically engineered virus improves survival time by 18 months in Phase 1 trial. (more…)
Written by Joyce Smith, BS. Treatment of malignant pleural mesothelioma cells with artichoke leaf extract significantly decreased cell growth and proliferation and increased apoptosis (cell death). (more…)
Written by Joyce Smith, BS. This study compares the clinical characteristics of a young subset of mesothelioma patients to those who are older and generates survival times for both groups from the data. (more…)
Written by Elwood Richard, BS. A touching article by Elwood Richard, who developed malignant pleural mesothelioma from asbestos exposure as a young man. (more…)
Written by Joyce Smith, BS. Study shows RANTES has the potential to be a critical biomarker for MM prognosis. (more…)
Written by Chrystal Moulton, Staff Writer. Study shows B7-H1 could serve as a biomarker for early detection of malignant pleural mesothelioma. (more…)
Written by Marcia J. Egles, MD. Study shows that higher total carotenoids were associated with 18-28% statistically lower risk of breast cancer. (more…)
Written by Joyce Smith, BS. NGR-hTNF has low toxicity and potential as a treatment for malignant pleural mesothelioma when used in combination with chemotherapeutic agents. (more…)
Written by Joyce Smith, BS. This study demonstrates that serum survivin can function as a useful biomarker in the treatment of malignant mesothelioma.
(more…)
Written by Greg Arnold, DC, CSCS. Analyzed data on 77,659 participants in The Adventist Health Study 2 revealed that when compared to non-vegetarians, all those in the vegetarian groups had a 19% borderline statistically significant reduced risk of colon cancer and a 22 % non-statistically significant reduced risk of colorectal cancers. (more…)
Written by Jessica Patella, ND. This large, 30-year study of nurses determined that those who consumed two or more servings of nuts per week had a significantly lower incidence of pancreatic cancer than those who almost never ate nuts. (more…)